Table 1.
Patient and tumor characteristics. NSCLC: non-small cell lung cancer; ACE: angiotensin-converting enzyme.
| Characteristics | Number of Patients (%) Beta-Blockers (n = 16) |
Number of Patients (%) No Beta-Blockers (n = 61) |
p Value |
|---|---|---|---|
| Sex | 0.99 | ||
| Female | 6 (38) | 23 (38) | |
| Male | 10 (62) | 38 (62) | |
| Age, years | 0.29 | ||
| <65 | 5 (31) | 28 (46) | |
| ≥65 | 11 (69) | 33 (54) | |
| T Category | 0.24 | ||
| T1,2 | 10 (63) | 47 (77) | |
| T3,4 | 6 (38) | 14 (23) | |
| N Category | 0.32 | ||
| N0,1 | 3 (19) | 6 (10) | |
| N2 | 13 (81) | 55 (90) | |
| Tumor Histology | |||
| Squamous cell | 6 (38) | 13 (21) | 0.18 |
| Adenocarcinoma | 6 (38) | 31 (51) | |
| NSCLC, not otherwise specified (NOS) | 4 (25) | 17(28) | |
| Radiation Dose, Gy | 0.70 | ||
| <60 | 7 (54) | 23 (48) | |
| ≥60 | 6 (46) | 25 (52) | |
| Aspirin | 0.02 | ||
| No | 10 (62) | 53 (87) | |
| Yes | 6 (38) | 8 (13) | |
| ACE inhibitor | <0.01 | ||
| No | 11 (69) | 57 (93) | |
| Yes | 5 (31) | 4 (7) |